Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab with Neoadjuvant Chemotherapy and IMRT in Nasopharyngeal Carcinoma
NCT01271439Phase 2Completed
- Sponsor
- Sun Yat-sen University
- Start
- Sep 2010
- Primary completion
- Jun 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in nasopharyngeal carcinoma (NPC), sponsored by Sun Yat-sen University. Started Sep 2010; status: completed.
02
Drugs
KL-140
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT01271439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01271439.